Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00550654 · OUTCOME

Median Time to Local Progression

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain · Source last updated 2017-01-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
6-12 months

What was measured

Interval from initiation of treatment on protocol to symptomatic or radiographic progression.

Analysis population: No data/specimens were collected. Study was terminated due to poor accrual.

Groups in this outcome

Radiation Therapy in Metastatic Cancer

Patients undergo hypofractionated highly conformal radiotherapy with helical tomotherapy once every other day over 5 days for a total of 3 fractions.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Radiation Therapy in Metastatic Cancer0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    units
    Participants
description
Interval from initiation of treatment on protocol to symptomatic or radiographic progression.
groups
  1. description
    Patients undergo hypofractionated highly conformal radiotherapy with helical tomotherapy once every other day over 5 days for a total of 3 fractions.
    id
    OG000
    title
    Radiation Therapy in Metastatic Cancer
population Description
No data/specimens were collected. Study was terminated due to poor accrual.
reporting Status
POSTED
time Frame
6-12 months
title
Median Time to Local Progression
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice